mhurhangee/ep-ind-claims huggingface dataset:
A method for controlling transmission of privacy information, comprising: receiving, by a first Push-To, PT, server, a session invitation for inviting at least one second PT client in an automatic answer mode to a PT session from a first PT client; receiving, by the first PT server, a first message relating to a progress status of the session from a second PT server, the first message including privacy information of one of the at least one second PT client, the privacy information indicating whether or not an identity of the one of the at least one second PT client is to be kept private; and transmitting, by the first PT server, a second message in response to the first message to the first PT client, wherein the second message selectively includes identification information of the one of the at least one second PT client based on the privacy information. receiving, by a first Push-To, PT, server, a session invitation for inviting at least one second PT client in an automatic answer mode to a PT session from a first PT client; receiving, by the first PT server, a first message relating to a progress status of the session from a second PT server, the first message including privacy information of one of the at least one second PT client, the privacy information indicating whether or not an identity of the one of the at least one second PT client is to be kept private; and transmitting, by the first PT server, a second message in response to the first message to the first PT client, wherein the second message selectively includes identification information of the one of the at least one second PT client based on the privacy information.
A method for preparing a tablet, comprising steps of: granulating while spraying an aqueous dispersion of low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxyl group substitution ranging from 5 to 16% by weight to a tablet-forming composition to obtain compression-moldable granules, wherein the low-substituted hydroxypropyl cellulose is water-insoluble, and tableting granules whose surfaces have been modified with the low-substituted hydroxypropyl cellulose to obtain the tablet. granulating while spraying an aqueous dispersion of low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxyl group substitution ranging from 5 to 16% by weight to a tablet-forming composition to obtain compression-moldable granules, wherein the low-substituted hydroxypropyl cellulose is water-insoluble, and tableting granules whose surfaces have been modified with the low-substituted hydroxypropyl cellulose to obtain the tablet.
An optical element comprising: a continuous gradient index distribution area which is configured to continuously attenuate gradient index from a center of the optical element in a radial direction, characterised by a first medium at the center, the first medium including an area where absolute value of imaginary part of a complex refractive index is greater than zero, whereby the area is configured to absorb light, wherein N = N 0 r 0 r m is fulfilled, in which N is a refractive index of the continuous gradient index distribution area, r is a radius from the center and is greater than 0, r 0 is a maximum value of the radius r, N 0 is a refractive index of an environment outside an outer peripheral surface of the optical element and is a constant, and m is a constant of 1 or more. a continuous gradient index distribution area which is configured to continuously attenuate gradient index from a center of the optical element in a radial direction, characterised by a first medium at the center, the first medium including an area where absolute value of imaginary part of a complex refractive index is greater than zero, whereby the area is configured to absorb light, wherein N = N 0 r 0 r m is fulfilled, in which N is a refractive index of the continuous gradient index distribution area, r is a radius from the center and is greater than 0, r 0 is a maximum value of the radius r, N 0 is a refractive index of an environment outside an outer peripheral surface of the optical element and is a constant, and m is a constant of 1 or more.
An absorbent article (1; 100) comprising an absorbent core (5; 105), the absorbent core (5; 105) comprising absorbent material, the absorbent core (5; 105) being sandwiched between a liquid-permeable upper core cover layer (11; 111) and a lower core cover layer (12; 112), the article (1; 100) having a longitudinal direction and a transverse direction perpendicular to the longitudinal direction, the absorbent core (5; 105) having a first side edge (18; 118) and a second side edge (19; 119), the first side edge (18; 118) and the second side edge (19; 119) of the absorbent core (5;105) each extending in the longitudinal direction, the upper core cover layer (11; 111) and the lower core cover layer (12; 112) being connected along the side edges (18, 19; 118, 119) of the absorbent core (5;105), the absorbent core (5;105) having one or more elongated areas (9, 10; 109, 110) arranged therein, each elongated area (9, 10; 109, 110) being an absorbent material free area (9, 10; 109, 110) and having a main extension in the longitudinal direction with a length (l f) as measured along the elongated area (9, 10; 109, 110) and a width (w f) in the transverse direction, wherein the upper core cover layer (11; 103) and the lower core cover layer (12; 104) in each of the one or more elongated absorbent material free areas (9, 10; 109, 110) are attached to each other within at least 2 attachment zones (13;113) and at most 12 attachment zones (13;113), the attachment zones (13;113) being spaced-apart in the longitudinal direction within each of the one or more absorbent material free areas (9, 10; 109, 110), wherein the attachment zones (13; 113) are spaced apart in the longitudinal direction with a closest distance in the longitudinal direction between neighboring attachment zones of from 15 millimeters to 119 millimeters..
A surgical imaging system comprising: a multispectral electromagnetic radiation source configured to emit EMR at a first wavelength range and a second wavelength range; an image sensor configured to sense the EMR at each of the first wavelength range and the second wavelength range reflected from a target site; and a control circuit coupled to the image sensor; wherein the control circuit is configured to: generate a first image of the target site according to the EMR emitted at the first wavelength range; generate a second image of the target site according to the EMR emitted at the second wavelength range; determine whether the first image is at least partially obstructed; and generate a fused image comprising a fusion between an unobstructed segment of the first image and a segment of the second image corresponding to an obstructed segment of the first image. a multispectral electromagnetic radiation source configured to emit EMR at a first wavelength range and a second wavelength range; an image sensor configured to sense the EMR at each of the first wavelength range and the second wavelength range reflected from a target site; and a control circuit coupled to the image sensor; wherein the control circuit is configured to: generate a first image of the target site according to the EMR emitted at the first wavelength range; generate a second image of the target site according to the EMR emitted at the second wavelength range; determine whether the first image is at least partially obstructed; and generate a fused image comprising a fusion between an unobstructed segment of the first image and a segment of the second image corresponding to an obstructed segment of the first image. generate a first image of the target site according to the EMR emitted at the first wavelength range; generate a second image of the target site according to the EMR emitted at the second wavelength range; determine whether the first image is at least partially obstructed; and generate a fused image comprising a fusion between an unobstructed segment of the first image and a segment of the second image corresponding to an obstructed segment of the first image.
A process to purify a compound comprising: (i) a suspension crystallization step, (ii) a layer crystallization step, (iii) a storage step, characterized in that the liquid feed of the compound to be purified is fed to the layer crystallization step so as to obtain a reject stream and an intermediate product stream, wherein the intermediate product strean obtained from the layer crystallization step is stored in the storage step before it is fed for further purification in the suspension crystallization step, wherein any suspension crystallization step or stage present in the process comprises a solid-liquid separation and washing stage, and wherein the solid-liquid separation and washing stage is carried out in a wash column having a melt circuit (52, 511, 55). (i) a suspension crystallization step, (ii) a layer crystallization step, (iii) a storage step,
A method for facilitating ultrasound viewing of a hyperechoic material (12, 16) adapted to be disposed within tissue, comprising the steps of: selecting at least one hyperechoic material (12,16) from a group of hyperechoic materials (12,16) including permanent and temporary, biodegradable hyperechoic materials (12,16); encapsulating said at least one hyperechoic material (12, 16) within a hypoechoic hydrogel material so that the hypoechoic hydrogel material surrounds the at least one hyperechoic material (12,16) and therefore is suitable to identify the location of the at least one hyperechoic material (12,16) under ultrasound viewing, wherein the hypoechoic hydrogel material comprises at least one air-filled cavity (18, 20), each air-filled cavity (18, 20) reflecting ultrasound in a way that is distinguishable from the hydrogel reflection. selecting at least one hyperechoic material (12,16) from a group of hyperechoic materials (12,16) including permanent and temporary, biodegradable hyperechoic materials (12,16); encapsulating said at least one hyperechoic material (12, 16) within a hypoechoic hydrogel material so that the hypoechoic hydrogel material surrounds the at least one hyperechoic material (12,16) and therefore is suitable to identify the location of the at least one hyperechoic material (12,16) under ultrasound viewing, wherein the hypoechoic hydrogel material comprises at least one air-filled cavity (18, 20), each air-filled cavity (18, 20) reflecting ultrasound in a way that is distinguishable from the hydrogel reflection.
A protected wheeled vehicle comprising two vehicle sections (1, 2), wherein at least one vehicle axle having two wheels each with one wheel at each end of the vehicle axle is arranged on each vehicle section (1, 2), wherein the vehicle sections (1, 2) are configured to be connected to one another via an articulation which serves as central space for a vehicle crew and is configured to be adjustable in its articulation angle, wherein several vehicle axles each having two wheels are provided on the preceding vehicle section during forward travel and at least two of these wheels are configured to be steerable, wherein the following vehicle section during forward travel is provided with a vehicle axle having two wheels each and wherein the following vehicle section during forward travel is configured to be turret-free and provided with a weapon.
A non-human animal model for muscle cell atrophy comprising: muscle cells comprising a nuclear genome comprising a biologically active atrogen gene encoding a functional protein, whose expression is induced in muscle cells exposed to an atrophy-inducing stimulus, in operable linkage with a reporter construct present in the 3' untranslated region or the 5' UTR of said atrogen gene, said reporter comprising: i. a first coding sequence for a fluorescent or luminescent detectable protein; and ii. a second coding sequence for a secreted reporter enzyme; wherein said secreted reporter enzyme and said detectable protein are induced by muscle cell atrophy and the production of said secreted reporter of said non-human animal can be non-invasively monitored in bodily fluids and said detectable protein of said non-human animal can be monitored by in vivo imaging. muscle cells comprising a nuclear genome comprising a biologically active atrogen gene encoding a functional protein, whose expression is induced in muscle cells exposed to an atrophy-inducing stimulus, in operable linkage with a reporter construct present in the 3' untranslated region or the 5' UTR of said atrogen gene, said reporter comprising: i. a first coding sequence for a fluorescent or luminescent detectable protein; and ii. a second coding sequence for a secreted reporter enzyme; i. a first coding sequence for a fluorescent or luminescent detectable protein; and ii. a second coding sequence for a secreted reporter enzyme; wherein said secreted reporter enzyme and said detectable protein are induced by muscle cell atrophy and the production of said secreted reporter of said non-human animal can be non-invasively monitored in bodily fluids and said detectable protein of said non-human animal can be monitored by in vivo imaging.
An instrument comprising: a hydrophilic processed portion on at least a portion of an outer surface thereof, wherein the hydrophilic processed portion contains a hydrophilic polymer and a silver-containing antibacterial agent, a water contact angle of a surface of the hydrophilic processed portion is equal to or less than 60 °, the hydrophilic processed portion further contains at least one kind of photocatalytic material containing a metal oxide, and an amount of silver ions per unit area of the hydrophilic processed portion that is measured by the following extraction test is equal to or greater than 15 ng/cm 2, Extraction condition: A 1/500 normal nutrient broth medium specified in JIS Z 2801:2010 is used as an extractant; a temperature of the extractant is controlled within a range of 35 ± 1°C; the extractant is brought into contact with the surface of the hydrophilic processed portion for 1 hour; an amount of silver ions extracted into the extractant is measured; the obtained value is divided by a contact area between the surface of the hydrophilic processed portion and the extractant, thereby obtaining an amount of silver ions per unit area; and herein, a unit of the amount of silver ions is ng, a unit of the contact area is cm 2, and a unit of the amount of silver ions per unit area is ng/cm 2. a hydrophilic processed portion on at least a portion of an outer surface thereof, wherein the hydrophilic processed portion contains a hydrophilic polymer and a silver-containing antibacterial agent, a water contact angle of a surface of the hydrophilic processed portion is equal to or less than 60 °, the hydrophilic processed portion further contains at least one kind of photocatalytic material containing a metal oxide, and an amount of silver ions per unit area of the hydrophilic processed portion that is measured by the following extraction test is equal to or greater than 15 ng/cm 2, Extraction condition: A 1/500 normal nutrient broth medium specified in JIS Z 2801:2010 is used as an extractant; a temperature of the extractant is controlled within a range of 35 ± 1°C; the extractant is brought into contact with the surface of the hydrophilic processed portion for 1 hour; an amount of silver ions extracted into the extractant is measured; the obtained value is divided by a contact area between the surface of the hydrophilic processed portion and the extractant, thereby obtaining an amount of silver ions per unit area; and herein, a unit of the amount of silver ions is ng, a unit of the contact area is cm 2, and a unit of the amount of silver ions per unit area is ng/cm 2.
Solid catalyst component with a) a Ti content (determined by ICP Analysis) in the range of 2.0 to 7.0 wt% b) a Mg content (determined by ICP Analysis) in the range of 8.0 to 15.0 wt% c) an Al content (determined by ICP Analysis) in the range of 0.0 to 0.4 wt% d) an mean particle size (determined by using a Coulter Counter LS200 at 25°C in n-heptane) in the range of 2 to 500 μm, preferably 5 to 200 μm, more preferably 10 to 100 μm e) and an internal donor in the range of 15.0 to 45.0 wt%, the internal donor being selected from 1-cyclohexene-1,2-dicarboxylic diesters of formula with R 1 and R 2 being identical or different and can be linear or branched C 1 -C 3 -alkyl, linear, branched or cyclic C 5 -C 20 -alkyl or C 6 -C 10 -aryl, and R 3 to R 6 may be identical or different and can be hydrogen or a linear or branched C 1 to C 6 alkyl or a C 6 -C 10 -aryl. a) a Ti content (determined by ICP Analysis) in the range of 2.0 to 7.0 wt% b) a Mg content (determined by ICP Analysis) in the range of 8.0 to 15.0 wt% c) an Al content (determined by ICP Analysis) in the range of 0.0 to 0.4 wt% d) an mean particle size (determined by using a Coulter Counter LS200 at 25°C in n-heptane) in the range of 2 to 500 μm, preferably 5 to 200 μm, more preferably 10 to 100 μm e) and an internal donor in the range of 15.0 to 45.0 wt%, the internal donor being selected from 1-cyclohexene-1,2-dicarboxylic diesters of formula with R 1 and R 2 being identical or different and can be linear or branched C 1 -C 3 -alkyl, linear, branched or cyclic C 5 -C 20 -alkyl or C 6 -C 10 -aryl, and R 3 to R 6 may be identical or different and can be hydrogen or a linear or branched C 1 to C 6 alkyl or a C 6 -C 10 -aryl. with R 1 and R 2 being identical or different and can be linear or branched C 1 -C 3 -alkyl, linear, branched or cyclic C 5 -C 20 -alkyl or C 6 -C 10 -aryl, and R 3 to R 6 may be identical or different and can be hydrogen or a linear or branched C 1 to C 6 alkyl or a C 6 -C 10 -aryl.
A method for erecting a wind turbine comprising a tower and a nacelle rotatably arranged on the tower, wherein the tower comprises a lower lattice structure, a transition and an upper cylinder, wherein the transition connects the upper cylinder to the lattice structure, the lattice structure comprising at least three corner posts (1.1) which are inclined at an angle to the vertical of the lattice structure relative to one another and define corner points at their lower ends relative to the vertical, which corner points span a base area, and the lattice structure having cross struts (1.2) and/or diagonal struts (1.3), wherein the lattice structure, the transition on the lattice structure, the cylinder on the transition and the nacelle on the cylinder are successively mounted, wherein at least one foundation for receiving the lower ends of the corner posts (1.1) is constructed at least in some areas before the wind turbine is erected, characterized in that that a tower slewing crane is provided for erecting the wind turbine, which is positioned and erected within the base area spanned by the corner points of the corner posts (1.1).
A method of detecting parasitic movements while aligning an inertial unit that comprises a navigation unit (1, 2) connected to accelerometer and angle sensors placed in a predetermined frame of reference (X,Y, Z), the method comprising the steps of: - integrating the signals from the sensors, in a frame of reference that is turning in an orientation that can be detected by the accelerometer and angle sensors, in order to obtain a raw position signal during a predetermined duration; - recording the raw position signal during said predetermined duration; characterized in that the method further comprises the steps of: - determining the parameters of a theoretical signal modeling the raw position signal as a function of a predetermined error model in the absence of movement so that the theoretical signal, along each axis as a function of time, is modeled by a polynomial function; - calculating a residual signal between the theoretical modeling signal (Sr) and the raw position signal; - identifying a parasitic movement when the residual signal overshoots a predetermined limit threshold (Sl). - integrating the signals from the sensors, in a frame of reference that is turning in an orientation that can be detected by the accelerometer and angle sensors, in order to obtain a raw position signal during a predetermined duration; - recording the raw position signal during said predetermined duration; - determining the parameters of a theoretical signal modeling the raw position signal as a function of a predetermined error model in the absence of movement so that the theoretical signal, along each axis as a function of time, is modeled by a polynomial function; - calculating a residual signal between the theoretical modeling signal (Sr) and the raw position signal; - identifying a parasitic movement when the residual signal overshoots a predetermined limit threshold (Sl).
A joint arrangement of at least two body components (1, 2) of a vehicle having a first joint component and at least a second joint component, wherein at least one holding device is provided for the lockable connection, and in addition to the at least one holding device at least one adhesive point is provided on the joint regions of the joint components, so that at least in one region joint components glued together are fixed by the holding device in their positioning relative to each other during the curing process of the adhesive, characterized in that at least one holding device has a pin and a counterpart, which are connected to each other via a holding element lying in between.
An in vitro method for determining the vaccination or infection status of an animal for Ehrlichia canis, the method comprising: (a) contacting a biological sample from the animal with a reagent comprising one or more first purified E. canis polypeptides comprising SEQ ID NOs: 2, 16, 17, or combinations thereof; and (b) detecting whether the one or more first purified E. canis polypeptides specifically bind to an antibody in the biological sample; wherein if the one or more first purified E. canis polypeptides specifically bind to an antibody in the sample, then the animal is infected with E. canis and, if the one or more first purified E. canis polypeptides do not specifically bind to an antibody in the sample, then the animal is either not infected with E. canis or has been vaccinated with a vaccine that does not comprise the one or more first purified E. canis polypeptides. (a) contacting a biological sample from the animal with a reagent comprising one or more first purified E. canis polypeptides comprising SEQ ID NOs: 2, 16, 17, or combinations thereof; and (b) detecting whether the one or more first purified E. canis polypeptides specifically bind to an antibody in the biological sample;